# Evolyzer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evolyzer

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.evolyzer.com
- Total disclosed funding: $28M
- Latest round: Series B (Mar 7, 2025)
- Investors on record: 10

## About

Established in 2022 and based in Beijing, China, Evolyzer operates as a biotechnology company dedicated to the research and development of synthetic biology. It has production bases in Shandong and Hangzhou. The company's founder and chief scientist officer (CSO), Dr. Huimin Yu, is a professor in the Department of Chemical Engineering at Tsinghua University. The company has obtained 21 invention patents and acquired certifications such as ISO9001, ISO14001, and ISO45001. In July 2024, it raised over CNY 150 million in series A funding co-led by new investors SinoKing Capital and E-Town International Industrial Investment.

The company provides agricultural and food solutions, energy and chemical solutions, daily chemical and medical beauty solutions, and medical and pharmaceutical solutions. The agricultural and food solutions is green agricultural products with biological activation factors as the core, which provides water-soluble fertilizers, microbial agents, and bio-synergists. Evolyzer also provides business biocatalysts, bio-templated nano and single-atom metal catalysts, and specialty chemicals. The products can be used in agriculture, daily chemicals, medicine and other fields.

The company generates revenue by providing chemicals and solutions developed through biotechnology such as agricultural and food solutions and energy and chemical solutions.

## Funding rounds

- Series B, Mar 7, 2025 — SDIC Chuangyi
- Series A, Jul 31, 2024, $21M — CDH Investments, E-Town International Industrial Investment, HSG, SinoKing Capital, Frees Fund, HWealth Capital
- Angel, Jun 6, 2022, $7.5M — Hong Shan, Frees Fund, Tsinghua Innovation Ventures
- Seed, Feb 25, 2022 — T-Capital

## Investors

- T-Capital — Seed
- Hong Shan — Angel
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Angel, Series A
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Angel
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series A
- E-Town International Industrial Investment (https://capitalatlas.ai/funds/e-town-international-industrial-investment) — Series A
- HSG (https://capitalatlas.ai/funds/hsg) — Series A
- SinoKing Capital (https://capitalatlas.ai/funds/sinoking-capital) — Series A
- HWealth Capital (https://capitalatlas.ai/funds/hwealth-capital) — Series A
- SDIC Chuangyi (https://capitalatlas.ai/funds/sdic-chuangyi) — Series B